phosphorylation increases the cleavage of APP by the amyloidogenic pathway, which generates A ␤ within the ER lumen, and releases Fe65 into the cytoplasm. Part of the released Fe65 translocates into the nucleus, likely to initiate a gene transcription response to arrested transport. Prolonged arrest of kinesin-1-dependent transport could thus lead to accumulation and oligomerization of A ␤ in the ER.
of axonal transport could lead to AD, but the mechanisms are poorly defined [2] . We hypothesize that a complex of APP and Fe65, a well-characterized APP-binding protein, is a sensor localized to the endoplasmic reticulum (ER) that detects and signals to the nucleus abnormalities in axonal transport. Prolonged activation of this signaling pathway due to chronically slowed-down axonal transport -likely to occur in AD -could lead to increased production and intracellular accumulation of A ␤ . We propose a model ( fig. 1 ) where a complex containing APP, Fe65 and kinesin-1 -normally transported into neurites -accumulates at ER when axonal transport is arrested and the level of kinesin-1 in the soma is increased. This complex recruits c-Jun N-terminal kinase (JNK), which phosphorylates APP, resulting in cleavage of the phosphorylated APP via the amyloidogenic pathway and accumulation of oligomerization-prone A ␤ in the ER lumen. Concomitantly, Fe65 is released, and translocates into the nucleus to regulate expression of stress-related genes, including the AD-relevant kinase, GSK3 ␤ .
Methods
CAD cells, a CNS-derived neuronal cell line [3] , provide an excellent system for studying APP transport and metabolism, including intracellular accumulation of A ␤ [4] [5] [6] [7] [8] [9] [10] , a process typical for neurons of the aging brain [11] that is poorly reproduced in primary cultures of embryonic neurons. Mouse hippocampal neurons were used for confirmation purposes. Immunocytochemical, biochemical, and molecular biology approaches were employed as described previously [4] [5] [6] [7] [8] [9] [10] . Moderate overexpression of the HA-tagged, cargo-binding, tetratricopeptide repeat (TPR) domain of the kinesin-1 light chain (KLC), HA-KLC-TPR, was used to experimentally mimic the halted axonal transport in CAD cells, when kinesin-1 accumulates in the soma.
Results
The model of ER response to stress caused by impeded axonal transport proposed here ( fig. 1 ) is supported by our previous studies, as well as by the new results shown herein ( fig. 2-4 ). Key findings, pertinent to each step of the model, are listed below.
(1) We showed that, under normal conditions, a fraction of APP is transported into neurites by kinesin-1, recruited by Fe65, an adaptor protein that simultaneously binds the cytoplasmic domain of APP, and kinesin-1 (via the TPR domain of KLC) [12] ( fig. 1 a) .
(2) We showed that, blocking axonal transport by various means -e.g. osmotic stress -leads to accumulation of kinesin-1, Fe65, and APP in the soma [9] , and formation of an APP:Fe65:kinesin-1 complex at the ER [13] . (3) Our previous results indicate that the APP:Fe65: kinesin-1 complex, accumulates at the ER, recruits active JNK, binds to the JNK-interacting protein-3 (JIP-3) scaffold, and phosphorylates APP ( fig. 1 b) . Indeed, this APP phosphorylation is facilitated by, and requires, JIP-3 [6] , Fe65, and KLC [13] , and is augmented by stress [9] .
(4) We hypothesize that the Fe65-and kinesin-1-dependent phosphorylation of APP facilitates its cleavage via the amyloidogenic pathway, and thus increases the generation and oligomerization of A ␤ in the ER lumen ( fig. 1 c) . Consistent with this scenario, we show that the amount of oligomerized A ␤ that accumulates in the ER region is positively regulated by the levels of Fe65 ( fig. 2 ) and kinesin-1 ( fig. 3 ), manipulated experimentally with Fe65 siRNA, or expression of HA-KLC-TPR.
(5) We hypothesize that phosphorylation and cleavage of APP, caused by increased levels of kinesin-1 in the soma, leads to the release of Fe65, which translocates into the nucleus ( fig. 1 c) . Our data show that the nuclear level of Fe65 is increased upon expression of HA-KLC-TPR ( fig. 4 ) .
The proposed model is consistent with findings from other laboratories, showing that: (1) Thr 668 -phosphorylated APP is a better substrate for the ␤ -secretase, BACE1 than nonphosphorylated APP [14] ; (2) phosphorylation of APP at multiple residues reduces its affinity for Fe65 [15, 16] , and facilitates release of Fe65, and (3) Fe65 is part of a transcriptionally active complex, together with Tip60 [17, 18] . Interestingly, one of the genes upregulated by Fe65 could be GSK3 ␤ ; this kinase is activated in AD, and phosphorylates the microtubule-associated protein tau, leading to its release from the microtubules and enhancement of axonal transport.
Conclusions
The ER stress response triggered by slowed-down axonal transport described here explains both the A ␤ and the tau pathology characteristic for AD. According to our model, APP is a sensor that measures the pace of axonal transport. It detects variations in kinesin-1 levels, and triggers a stress response that signals to the nucleus abnormalities in axonal transport. A persistent stress response to impeded axonal transport, causing oligomerization and accumulation of A ␤ in the ER, and abnormal phosphorylation of tau, could be a pathogenic mechanism in sporadic AD. This and other studies [19, 20] confer to the ER a prominent role in the disease mechanism in AD. 
